The Traqr Blog
Plain-language GLP-1 guides, reviewed by clinicians.
Clinician-reviewed articles on starting GLP-1 medications, side effects, insurance coverage, and nutrition — written for people in treatment, not the trade press.
Is Your Compounding Pharmacy Actually at Risk? 503A vs 503B Explained for GLP-1 Patients
The FDA's 503B proposal alarmed GLP-1 patients — but most are through 503A pharmacies, which are a different category entirely. Here's what it actually means.
Browse by topic
Getting StartedPlain-language guides for people just starting GLP-1 therapy.1 articleSide EffectsWhat to expect, what is normal, and when to call your doctor.0 articlesInsurance & CostCoverage, copays, manufacturer programs, and Medicaid/Medicare specifics.1 articleNutritionEating well while on GLP-1s — protein targets, hydration, and meal timing.0 articlesPolicy & RegulationFDA decisions, coverage rules, and regulatory changes that affect GLP-1 access.1 articleNewsTime-sensitive updates on GLP-1 medications, manufacturers, and coverage programs.0 articlesExplainersPlain-language explainers on programs, terminology, and the wider GLP-1 landscape.0 articles
Latest
- Insurance & CostWhat the Medicare GLP-1 Bridge actually costs you (and what it doesn't)Starting July 1, 2026, Medicare's $50/month GLP-1 Bridge arrives—but it won't count toward your deductible or $2,100 out-of-pocket cap. Here's what you'll pay.
- Getting StartedWelcome to the Traqr BlogA short note about what this blog will cover, how we review our posts, and what to expect over the coming months.